Atria Investments’s VanEck CLO ETF CLOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Buy
28,809
+1,401
+5% +$73.9K 0.02% 834
2025
Q4
$1.45M Sell
27,408
-4,550
-14% -$241K 0.02% 881
2025
Q3
$1.7M Sell
31,958
-25,877
-45% -$1.37M 0.02% 788
2025
Q2
$3.06M Sell
57,835
-12,595
-18% -$663K 0.04% 556
2025
Q1
$3.72M Buy
70,430
+38,421
+120% +$2.03M 0.05% 458
2024
Q4
$1.69M Buy
32,009
+27,716
+646% +$1.47M 0.02% 751
2024
Q3
$228K Sell
4,293
-151
-3% -$7.98K ﹤0.01% 1763
2024
Q2
$235K Buy
+4,444
New +$235K ﹤0.01% 1729

Other funds holding CLOI

Atria Investments's CLOI Position: Q1 2026 in Review

Atria Investments increased its VanEck CLO ETF (CLOI) stake by 5.1% in Q1 2026, buying an estimated $73.9K and bringing the position to 28,809 shares worth $1.52M. The position accounts for 0.02% of the portfolio, ranked #834.

Atria Investments first reported a position in CLOI in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.72M in Q1 2025. 167 funds tracked by Wall St. Rank hold CLOI as of Q1 2026.

  • Atria Investments held 28,809 shares of VanEck CLO ETF worth $1.52M as of Q1 2026.
  • Atria Investments bought 1,401 VanEck CLO ETF shares in Q1 2026, an estimated $73.9K.
  • VanEck CLO ETF made up 0.02% of Atria Investments's portfolio in Q1 2026, its #834 holding.
  • Atria Investments first reported a position in VanEck CLO ETF in Q2 2024 and has held it in 8 quarters since.
  • Atria Investments's VanEck CLO ETF position peaked at $3.72M in Q1 2025.
  • 167 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.